期刊文献+

冠状动脉粥样硬化患者外周血单个核细胞抗菌肽α防御素和组织蛋白酶抑制素基因的表达变化 被引量:1

Expression Levels of alpha-Defensins and Cathelicidin are Upregulated in Peripheral Mononuclear Blood Cells of Patients with Coronary Atherosclerosis
在线阅读 下载PDF
导出
摘要 目的探讨外周血单个核细胞抗菌肽α防御素和组织蛋白酶抑制素基因表达水平与冠状动脉粥样硬化的关系。方法冠状动脉粥样硬化性心脏病组61例,为临床症状符合稳定型劳力性心绞痛,且冠状动脉造影发现左主干直径狭窄≥50%,或左前降支、左回旋支和右冠状动脉主支至少一处病变直径狭窄≥75%的患者;对照组53例,为经冠状动脉造影排除冠状动脉粥样硬化性心脏病者。冠状动脉造影前获得空腹静脉血进行血常规和高敏C反应蛋白检测、提取总核糖核酸并合成互补脱氧核糖核酸用于实时定量RT-PCR。结果冠状动脉粥样硬化性心脏病组糖尿病比例(34.4%比15.1%,P=0.03)、合并闭塞性动脉硬化和(或)缺血性脑卒中病史比例(19.7%比0.0%,P=0.0006)均高于对照组。冠状动脉粥样硬化性心脏病组淋巴细胞百分比低于对照组(27.2%±1.2%比31.7%±1.5%,P=0.02),高敏C反应蛋白水平高于对照组[2.0(1.0~4.0)mg/L比1.0(0.5~2.4)mg/L,P=0.02)]。冠状动脉粥样硬化性心脏病组组织蛋白酶抑制素表达水平[1.21(0.98~1.55)比0.97(0.69~1.39),P=0.009)]、α防御素1-3表达水平[0.85(0.58~1.21)比0.61(0.41~0.86),P=0.003)]和α防御素4表达水平[0.78(0.52~1.43)比0.47(0.32~0.74),P=0.001)]均高于对照组。组织蛋白酶抑制素基因表达水平同嗜碱性粒细胞分类水平相关(rs=0.19,P=0.04)。结论稳定型劳力性心绞痛患者外周血单个核细胞抗菌肽组织蛋白酶抑制素和α防御素1-4基因持续高表达可能与冠状动脉粥样硬化有关。 Aim To evaluate expression levels of the 5 kinds of antimicrobial peptide genes,cathelicidin(CAMP)and alpha-defensin 1-4(DEFA1-4)in peripheral blood mononuclear cells(PBMC).Methods Sixty-one patients with coronary artery disease(CAD)who had stable effort angina pectoris and had ≥50% diameter stenosis in left main coronary artery or at least one major coronary artery were involved in this study.Controls(n=53)were those with chest pain,abnormal ecletronic cadiogram or abnormal echocardiography,but had a smooth coronary angiogram(CAG).Venous blood was obtained before CAG for RNA isolation and routine blood count.Ten μg/patient of the total RNA were used for individual cDNA preparation.Expression levels of genes in individuals were evaluated by quantitative real-time RT-PCR.Results WBC count and subset counts were not different between CAD and control group,except that relative lymphocyte count in percentage was lower in the former than that in the later(27.2%±1.2% vs 31.7%±1.5%,P=0.02).Level of CAMP gene expression was higher in CAD than that in the control [1.21(0.98~1.55)vs 0.97(0.69~1.39),P=0.009)].Expression levels of DEFA 1-3 genes were elevated in CAD than that in the control[0.85(0.58~1.21)vs 0.61(0.41~0.86),P=0.003)].CAD group also presented higher expression level of DEFA 4 gene than the control group [0.78(0.52~1.43)vs 0.47(0.32~0.74),P=0.001)].The differences of these gene expression levels were not due to variations of WBC subset counts as judged by correlational analysis(all P〉0.05).CAD patients had higher hs-CRP level than the controls [2.0(1.0~4.0)mg/L vs 1.0(0.5~2.4)mg/L,P=0.02)].Expression levels of DEFA1-3,DEFA4,CAMP were not correlated with CRP level.Conclusion Expression levels of antimicrobial peptides,alpha-defensins and cathelicidin in PBMC,may be associated with coronary artery atherosclerosis.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2010年第3期223-226,共4页 Chinese Journal of Arteriosclerosis
基金 北京市自然科学基金(7082030) 北京市优秀人才基金(20081D0300600080) 首都医科大学临床基础合作课题(2007JL42)部分资助
关键词 抗菌肽 防御素 组织蛋白酶抑制素 动脉粥样硬化 Antimicorbial Peptides Defensin Cathelicidin Atherosclerosis
  • 相关文献

参考文献19

  • 1Libby P. Inflammation in atheroaclerosis [J]. Nature, 2002, 420 (6917): 868-874.
  • 2范乐明.动脉粥样硬化炎症机制的再认识[J].中国动脉硬化杂志,2005,13(3):249-253. 被引量:73
  • 3Bamathan ES, Raghunath PN, Tomaszewski JE, et al. Immunohistoehemical localization of defensin in human coronary vessels [J]. Am J Pathol,1997,50 (3) : 1 009-020.
  • 4Higazi AA, Lavi E, Bdeir K, et al. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells [J]. Blood, 1997, 89 (12): 4 290-298.
  • 5Kougias P, Chai H, Lin PH, et al. Neutrophil antimicrobial peptide alpha-defensin causes endothelial dysfunction in porcine coronary arteries [J]. J Vase Surg, 2006, 43 (2) : 357-363.
  • 6Kougias P, Chai H, Lin PH, et al. Defensins and cathelicidins: neutrophil peptides with roles in inflammation, hyperlipidemia and athevasclerosis [J]. J Gell Mol Med, 2005,9(1):3-10.
  • 7Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 [J]. J Clin Insest, 2003, 111 (11) : 1 665-672.
  • 8Ciomei CD, Tapper H, Bjartell A, et al. Human antimicrobial peptide LL-37 is present in athereselerotic plaques and induces death of vascular smooth muscle cells: a laboratory study [J]. BMC Cardiovasc Disord, 2006, 6: 49.
  • 9Wilde CG, Griflqth JE, Mama MN, et al. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family [J]. J Biol Chem, 1989, 264 (19) : 11 200-203.
  • 10杨小蓉,金小宝,朱家勇.抗菌肽LL-37在动脉粥样硬化中的研究[J].医学综述,2008,14(15):2330-2333. 被引量:3

二级参考文献83

  • 1Roes R. Atherosclemsis - an inflammatory disease. N Engl J Med, 1999,340:115-126.
  • 2Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages contributions to atherosclerosis.Arterioscler Thromb Vasc Biol, 2004, 24(1): 23-28.
  • 3Rama Natarajan, Nadler JL.Lipid Inflammatory Mediators in Diabetic Vascular Disease.Arterioscler Thromb Vasc Biol,2004,24:1542-548.
  • 4Hosono M, de Boer OJ, van der Wal AC, van der Loos CM, Teeling P, Piek JJ,et al.Increased expression of T cell activation markers (CD25,CD26,CD40Land CD69)in atherectomy specimens of patients with unstable angina and acute myocardial infarction.Atherosclerosis,2003,168:73-80.
  • 5Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med, 2002, 347(1): 5-12.
  • 6Libby P. Inflammation in atherosclemsis. Nature,2002,420:868-874.
  • 7Miller YI,Chang MK, Binder CJ, Shaw PX, Witztum JL. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol, 2003, 14: 437-445.
  • 8Maggi E, Perani G, Falaschi F, Frattoni A, Martignoni A, Finardi G, et al.Autoantibodies against oxidized low density lipoproteins in patients with coronary disease. Presse Med, 1994, 23: 1158-162.
  • 9Mehta JL, Saldeen TG, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosos and coronary artery disease. J Am Coll Cardiol, 1998, 31:1217-225.
  • 10Hofman A. Lipopotein-associated phospholipase A2 is associated with risk of coronary heart disesse and stroke. The Rotterdam study. Presented at the European Society of Cardiology Congress 2004. Munich, Germarry, 30 August 2004.

共引文献74

同被引文献4

  • 1Libby P, Okamoto Y, Rocha VZ, et al. Inflammation in atherosclerosis: transition from theory to practice [ J ]. Circ J, 2010, 74(2): 213-220.
  • 2Maier W, Altwegg EA, Corti R, et al. Inflammatory mark- ers at the site of ruptured plaque in acute myocardial infarc- tion: locally increased imerleukin-6 and serum amyloid A but decreased C-reactive protein [ J ]. Circulation, 2005, 111(11) : 1 355-361.
  • 3Bdeir K, Cane W, Canziani G, et al. Defensin promotes the binding of lipoprotein (a) to vascular matrix [ J ]. Blood, 1999, 94(6) : 2 007-019.
  • 4Chavakis T, Cines DB, Rhee JS, et al. Regulation of neovascularization by human neutrophil peptides (alpha- defensins) : a link between inflammation and angiogenesis [J]. FASEB J, 2004, 18(11) : 1 306-308.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部